UMeWorld Positions DAGola(TM) for Strong Q4 Revenue Surge with U.S. E-Commerce and China Market Expansion
MWN-AI** Summary
UMeWorld Limited (OTC: UMEWF) is poised for a substantial revenue surge in Q4 2025, driven by the expansion of its flagship product, DAGola™, a revolutionary cooking oil scientifically designed for health-conscious consumers. Utilizing advanced enzymatic technology, DAGola™ boasts high-purity diacylglycerol (DAG) that not only enhances culinary experience but also supports fat metabolism, reduces triglyceride levels, and lowers uric acid—a significant advancement in addressing metabolic syndromes.
The product's entry into prominent e-commerce platforms, including Walmart Marketplace and Amazon, significantly boosts its visibility to approximately 80% of online grocery shoppers in the United States. This strategic positioning is expected to drastically enhance U.S. revenues in the upcoming quarter. Complementing this online presence, UMeWorld is launching a targeted micro-influencer marketing campaign aimed at enhancing brand awareness and encouraging consumer trials.
Looking towards expansion, UMeWorld is collaborating with major distributors in China, aiming for DAGola™ to enter both online and offline retail channels by September, tapping into China’s lucrative $25 billion edible oil market. This move not only promises immediate revenue generation but also establishes a long-term foothold in the world's largest consumer market.
DAGola™ is backed by solid scientific evidence, with clinical studies showcasing its potential to reduce triglyceride formation significantly. UMeWorld's commitment to innovation extends to international markets, including Europe and Japan, leveraging partnerships and tailored marketing to introduce its product to a broader health-oriented audience. As UMeWorld prepares for these pivotal developments, it aims to assert itself as a leader in the next-generation cooking oil sector, emphasizing its mission to provide science-backed, functional nutrition solutions.
MWN-AI** Analysis
UMeWorld Limited (OTC: UMEWF) is poised for a robust fourth quarter in 2025, driven by the burgeoning presence of its flagship product, DAGola™, in key markets. As the demand for health-oriented cooking oils escalates, DAGola™ stands out with its clinically validated benefits, including triglyceride reduction and enhanced metabolic health. This positions UMeWorld uniquely against competitors, capitalizing on growing consumer preferences for functional food products.
Recently, securing distribution through Walmart Marketplace and Amazon significantly broadens DAGola™’s exposure, targeting approximately 80% of U.S. online grocery shoppers. This access not only accelerates potential revenue streams but lays the groundwork for an expansive micro-influencer marketing initiative aimed at building brand loyalty and consumer education. The company's strategy to penetrate mass-market retail chains further solidifies its distribution framework, which is critical for sustaining long-term growth.
In addition to its U.S. strategy, UMeWorld is eyeing the Chinese market, a move that presents vast revenue potential within the nation’s $25 billion edible oil sector. Collaborations with leading distributors signal a strategic approach to simultaneously addressing both online and offline retail channels, further diversifying revenue sources.
Investors should note that UMeWorld's initiatives not only focus on immediate gains but also emphasize sustained growth through international expansion, including future markets in Europe and Japan. With the health food sector continually shifting towards science-backed products, UMeWorld is well-positioned to leverage its innovative approach to cooking oils.
As 2025 progresses, UMeWorld could experience notable revenue surges, particularly in Q4, making it an attractive prospect for investors seeking exposure to the evolving health-conscious consumer market. Monitoring their execution of this strategic roadmap will be critical for evaluating performance and growth potential.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
MIAMI, July 22, 2025 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC:UMEWF) is pleased to provide a significant commercial update on the expansion of its flagship product, DAGola™, a clinically validated cooking oil formulated using advanced enzymatic technology to produce high-purity diacylglycerol (DAG).
DAGola™ is designed to meet the growing global demand for healthier, functional cooking oils. Unlike conventional oils, DAGola™ is scientifically formulated to support fat metabolism and is clinically proven to reduce triglycerides and lower uric acid levels - two critical markers associated with metabolic syndrome, obesity, and gout. These differentiators make DAGola™ a compelling choice for today’s health-conscious consumers seeking both culinary performance and metabolic support.
DAGola™ is now available on both Walmart Marketplace and Amazon, securing access to the two largest e-commerce grocery platforms in the United States. This milestone gives the brand exposure to approximately 80% of online grocery shoppers nationwide and is expected to significantly accelerate U.S. revenue contribution in the fourth quarter of 2025.
With these key online channels secured, the Company is launching a targeted micro-influencer marketing program to build brand awareness, educate consumers, and drive product trial. Looking ahead, the next strategic objective in the U.S. market is to secure shelf space in mass-market retail chains, including national supermarkets, club stores, and specialty health retailers.
In China, UMeWorld is actively collaborating with several leading national distributors to launch DAGola™ across both online and offline retail channels as early as September, pending production capacity. This expansion provides immediate access to China’s $25 billion edible oil market, presenting substantial near-term revenue opportunities while establishing a strong foundation for long-term brand growth in the world’s largest consumer economy.
These commercial achievements are underpinned by DAGola™’s strong scientific validation. Clinical studies have demonstrated the oil’s ability to reduce postprandial triglyceride formation by up to 80%, improve lipid metabolism, and support cardiovascular and metabolic health. These clinically proven benefits uniquely position DAGola™ in the global edible oil market, where consumer preferences are increasingly driven by demand for functional, health-enhancing products.
With U.S. e-commerce distribution firmly in place, influencer-led marketing initiatives underway, and China’s national rollout on track, UMeWorld is well-positioned to execute its 2025 commercial roadmap. Management expects these developments to significantly contribute to top-line growth and strengthen global brand equity over the coming quarters.
Beyond these core markets, UMeWorld is actively pursuing international expansion opportunities. Europe and Japan are near-term priorities, where the Company plans to leverage strategic partnerships and localized marketing initiatives to introduce DAGola™ to a broader base of health-conscious consumers. These efforts aim to capitalize on the growing global appetite for science-backed, functional nutrition while reinforcing UMeWorld’s position as a global innovator in next-generation cooking oils.
About UMeWorld
UMeWorld is redefining the cooking oil industry through science and innovation. Our flagship product, DAGola™, contains up to 80% less triglycerides than traditional oils and is clinically proven in multiple human trials to support heart health and improve lipid metabolism. Using a proprietary enzymatic technology, we produce functional oils that help combat metabolic syndrome, which affects over 47 million Americans 1 billion people globally. This same advanced process also converts palm and used cooking oils into eco-friendly biofuels. Our mission is to lead in next-generation nutrition and sustainable energy, delivering innovation with real-world impact.
About DAGola Inc.
DAGola Inc. is the U.S. branch of UMeWorld Limited. It focuses on selling innovative food products in North America. To learn more about DAGola Inc., visit www.dagolaoil.com .
Forward-Looking Statements
This press release may contain forward-looking statements, about UMeWorld's expectations, beliefs or intentions regarding, among other things, its product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, UMeWorld or its representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as "believe," "expect," "intend," "plan," "may," "should" or "anticipate" or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by UMeWorld with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of UMeWorld's authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause UMeWorld's actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause UMeWorld's actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements, including, but not limited to, the factors summarized in UMeWorld's filings with the SEC. In addition, UMeWorld operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. UMeWorld does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise. Please see the risk factors associated with an investment in our securities which are included in our Annual Report on Form 20-F and other periodic and current reports filed with the Securities and Exchange Commission.
CONTACT: Contact: Michael Lee CEO, UMeWorld Limited Email: info@umeworld.com
FAQ**
How does UMeWorld Ltd UMEWF plan to sustain its growth in the competitive market of cooking oils beyond the initial launch of DAGola™ on major e-commerce platforms?
What specific strategies will UMeWorld Ltd UMEWF employ to secure shelf space in national supermarkets and specialty health retailers across the U.S.?
Can you elaborate on the timeline and expected challenges UMeWorld Ltd UMEWF anticipates facing during the rollout of DAGola™ in China’s $25 billion edible oil market?
How does UMeWorld Ltd UMEWF intend to differentiate DAGola™ in the European and Japanese markets, and what localized marketing initiatives are planned to engage health-conscious consumers?
**MWN-AI FAQ is based on asking OpenAI questions about UMeWorld Ltd (OTC: UMEWF).
NASDAQ: UMEWF
UMEWF Trading
41900.0% G/L:
$0.42 Last:
1,000 Volume:
$0.42 Open:
